Objectives: Audit of current practice at the Bristol Adult CF Centre against the 2007 UK CF Trust recommendations in regard to dual-energy X-ray absorptiometry (DEXA) scans, calcium intake, vitamin D status and bisphosphonate treatment. Methods: A retrospective case note audit for patients that had an annual review in 2010. Data was compared with the 2007 UK CF Trust recommendations for bone health. Results: 106 patients were invited for annual review in 2010: 93 (88%) attended. Of these 93 patients 84 (90%) had a DEXA scan within the last 3 years, 7 (8%) did not attend, 1 (1%) refused and 1 (1%) scan was not ordered. Despite measures to optimise bone health, 17 (20%) patients still met clinical criteria for bisphosphonate treatment of whom 13 (15%) were receiving treatment. In 4 patients (5%) treatment was delayed for clinical reasons. 7 patients (8%) were taking bisphosphonates that no longer met the criteria. Serum 25-OH vitamin D was measured in 86 patients (
Background: Bone disease is a common complication that progresses with age, severity of lung damage and nutritional disorders in patients with cystic fibrosis (CF). Aim: To study the effect of calcium supplements and vitamin D on low bone mass density (BMD) in patients with CF. Materials and Methods: A group of 42 patients with CF was examined to measure low BMD status and the effects of therapy. Chest deformation was found in 1/3 of schoolchildren with CF and in two toddlers with a very severe disease evolution. Children with CF were divided into two groups: first group − 26 children younger than 12 years, and the second − 21 children older than 12 years. Calcium supplements with vitamin D were given to correct the low values of BMD in children with CF. This study lasted for 3 months. The control group consisted of 21 children with CF (8 children <12 years and 13 children >12 years) with no calcium supplements for the period of this study. Quantitative ultrasound was performed (Omnisense 7000P) and Z-score of BMD was assessed. Results: Initial Z-score showed decreased values in both study groups: −2.83±0.44 SD in CF children <12 years and −3.61±0.50 SD in CF patients >12 years. The level of initial Z-score in the control group were −2.73±0.51 SD (CF children <12 years) and −3.82±0.62 SD (CF children >12 years). Three months of treatment with calcium supplement produced an increase of Z-score to −2.44±0.47 SD in children <12 years and to −2.85±0.49 SD in older patients comparative to the control groups: −2.77±0.38 SD (p > 0.05) and −3.21±0.52 SD (p < 0.01). Conclusion: Calcium supplements with vitamin D in CF patients have a benefic influence on BMD Z-score.
309 Lactose intolerance is a risk factor for decreased bone mineral density in pancreatic insufficient cystic fibrosis children (FEV1), serum vitamin D 3 , calcium intake and single nucleotide polymorphism upstream of the lactase gene was assessed in all subjects.
In subjects with −13910C/C genotype (predisposing to adult-type hypolactasia), the presence of lactose malabsorption was assessed (hydrogen-methane breath test). With a use of logistic regression it was proved that BMD was dependent upon two qualitative factors: age (p < 0.03) and body weight (p < 0.04) and one quantitative factor: lactose malabsorption (p < 0.05). Such a relationship was not documented for lactase genotype.
In conclusion, lactose malabsorption seems to be an independent risk factor for decreased BMD in CF children. Objective: To determine the spectrum of skeletal and prevalence of CF-related low bone mineral density (BMD) in children and adults with CFTR I1234V mutation in a large Arab kindred family in Qatar. Methodology: Twenty-six CF patients aged more than 10 years who attended the CF clinic at Hamad Medical Corporation between November 2009 till April 2010. Lumbar spine, total hip, and whole-body bone mineral density were measured by DEXAscan. Serum Ca, phosphorus, alk. phosphatase, 25-OHD vitamin D, and vitamin K were measured. Age, gender, BMI, FEV1 and bacterial colonization were correlated with BMD. The Z score was used for those who were less than 21 years and T score was used in those who were 21 year or older. Results: Mean age of 17.29±4.95(SE) years, range 10−33 years. All the patients were pancreatic sufficient. Mean BMD Z scores for patients 20 years or younger were −0.69±0.96 (L1-L4), −0.49±0.92 (total hip), and −0.38±0.86 (total body). Mean BMD T scores for patients 21 years or older were 0.14± 1.13 (L1-L4), 0.38±1 (total hip) and 0.52±1.03 (total body). Seven CF patients had low BMD less than −1 giving the prevalence of CF-related low BMD of 26.9%. BMI correlated with BMD lumbar and total body Z or T scores but no significant correlation with hip Z or T score. Vitamin D deficiency was found in 20 CF patients (76.9%). BMD was not significantly correlated with gender, Pseudomonas aeruginosa and FEV1. Conclusion: CF-related low BMD does occur in patients with mild CFTR mutation associated with pancreatic sufficient. A larger study in a cohort of CF patients in the Arabian gulf region is required to determine the risk factors of CF-related bone disease
